In vivo studies further confirmed that RBM15 promotes NSCLC cell proliferation and metastasis via the KLF1–TRIM13/ANXA8 signaling axis (Wang et al., 2024). The gene discussed is KLF1; the disease is non-small cell lung carcinoma.